Keck School Faculty

Haris Zahoor
Haris Zahoor
Assistant Professor of Clinical Medicine
1500 San Pablo Street Health Sciences Campus Los Angeles

Next Generation Precision Medicine: CRISPR-mediated Genome Editing for the Treatment of Neurodegenerative Disorders J Neuroimmune Pharmacol. 2019 Dec; 14(4):608-641. . View in PubMed

CRISPR/Cas9 Editing of Glia Maturation Factor Regulates Mitochondrial Dynamics by Attenuation of the NRF2/HO-1 Dependent Ferritin Activation in Glial Cells J Neuroimmune Pharmacol. 2019 Dec; 14(4):537-550. . View in PubMed

The importance of not only living longer but also better in the setting of advanced urothelial cancer Ann Transl Med. 2019 Sep; 7(Suppl 6):S187. . View in PubMed

Brain Injury-Mediated Neuroinflammatory Response and Alzheimer's Disease Neuroscientist. 2019 May 16; 1073858419848293. . View in PubMed

Mast Cell Proteases Activate Astrocytes and Glia-Neurons and Release Interleukin-33 by Activating p38 and ERK1/2 MAPKs and NF-? B. Mol Neurobiol. 2019 Mar; 56(3):1681-1693.. View in PubMed

Phase II trial of continuous treatment with sunitinib in patients with high-risk (BCG-refractory) non-muscle invasive bladder cancer Invest New Drugs. 2019 12; 37(6):1231-1238. . View in PubMed

The Cancer Immunogram: A Pledge for a Comprehensive Biomarker Approach for Personalized Immunotherapy in Urothelial Cancer Eur Urol. 2019 03; 75(3):445-447. . View in PubMed

Evaluation of T cell infiltration in matched biopsy and nephrectomy samples in renal cell carcinoma Medicine (Baltimore). 2018 Sep; 97(37):e12344. . View in PubMed

Extended therapy breaks from VEGFR TKI therapy in renal cell carcinoma: Sometimes less is more Oncotarget. 2018 Mar 06; 9(18):14036-14037. . View in PubMed

Feasibility of Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer Patients With Diminished Renal Function Clin Genitourin Cancer. 2018 08; 16(4):e879-e892. . View in PubMed

Patient Characteristics, Treatment Patterns and Prognostic Factors in Squamous Cell Bladder Cancer Clin Genitourin Cancer. 2018 04; 16(2):e437-e442. . View in PubMed

Patterns, predictors and subsequent outcomes of disease progression in metastatic renal cell carcinoma patients treated with nivolumab J Immunother Cancer. 2018 10 17; 6(1):107. . View in PubMed

Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration Front Cell Neurosci. 2017; 11:216. . View in PubMed

Emerging growth factor receptor antagonists for the treatment of renal cell carcinoma Expert Opin Emerg Drugs. 2016 Dec; 21(4):431-440. . View in PubMed

Neuroinflammation Induces Neurodegeneration J Neurol Neurosurg Spine. 2016; 1(1). . View in PubMed

The revised American Joint Committee on Cancer staging system (7th edition) improves prognostic stratification after minimally invasive esophagectomy for esophagogastric adenocarcinoma Am J Surg. 2015 Oct; 210(4):610-7. . View in PubMed

Tumor associated PD-L1 expression pattern in microscopically tumor positive sentinel lymph nodes in patients with melanoma J Transl Med. 2015 Sep 30; 13:319. . View in PubMed

A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to neoadjuvant therapy for esophagogastric adenocarcinoma J Thorac Cardiovasc Surg. 2015 Feb; 149(2):538-47. . View in PubMed

Baseline circulating IL-17 predicts toxicity while TGF-ß1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma J Immunother Cancer. 2015; 3:39. . View in PubMed

Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-a but Not Observation in Intermediate Risk Melanoma Patients PLoS One. 2015; 10(7):e0132745. . View in PubMed

Phase I trial of carboplatin and etoposide in combination with panobinostat in patients with lung cancer Anticancer Res. 2013 Oct; 33(10):4475-81. . View in PubMed

Smoothened inhibition leads to decreased proliferation and induces apoptosis in esophageal adenocarcinoma cells Cancer Invest. 2013 Aug; 31(7):480-9. . View in PubMed

Powered by SC CTSI
Go to Top